Trial Profile
A comparative trial of adalimumab mono therapy and combination therapy with methotrexate in rheumatoid arthritis (RA) patients from the Rhumadata Clinical Database and Registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Feb 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 12 Feb 2016 New trial record